OOIR: Observatory of International Research

Papers

(The median citation count of Cancer Journal is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Toxicities From Antibody-Drug Conjugates	78
Social Drivers of Cancer Risk and Outcomes Among African American Men	44
HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer	35
PET Imaging of Metabolism, Perfusion, and Hypoxia	23
Oncology Physician Workforce Diversity	20
Individualizing Therapy for Malignant Gliomas	20
Building a Bridge to Equity in Health and Health Care in Cancer Care	19
Health Care Policy and Disparities in Health	19
Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer	17
Poly(ADP-Ribose) Polymerase Inhibitor Inhibition in Ovarian Cancer	17
Stereotactic Body Radiation Therapy	17
Clinical Evidence Generation During a Pandemic	17
Melanoma—Modern Treatment for Metastatic Melanoma	15
Therapeutic Response Assessment of High-Grade Gliomas During Early-Phase Drug Development in the Era of Molecular and Immunotherapies	14
The Principles and Practice of PARP Inhibitor Therapy	13
c-Met Signaling as a Therapeutic Target in Head and Neck Cancer	13
Measurable Residual Disease Assessment as a Surrogate Marker in New Drug Development in Acute Myeloid Leukemia	13
Prostate Cancer, Race, and Health Disparity	12
Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes	12
Nonoperative Management for Rectal Cancer	12
Aurora Kinases as Therapeutic Targets in Head and Neck Cancer	11
Clinical Targeting of Altered Metabolism in High-Grade Glioma	11
Germline Predisposition to Myelodysplastic Syndromes	11
Poly(ADP-Ribose) Polymerase Inhibitor Combination Therapy	11
Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma	11

Diversity in Cancer Care	10
Metastatic Melanoma Treatment in Special Populations	10
Primary Prevention of Cancer	10
Advanced Imaging and Computational Techniques for the Diagnostic and Prognostic Assessment of Malignant Gliomas	9
Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes	9
How We Incorporate Venetoclax in Treatment Regimens for Acute Myeloid Leukemia	9
Antibody Drug Conjugates in Multiple Myeloma	9
Are We Witnessing a Paradigm Shift in the Treatment of Acute Myeloid Leukemia?	8
Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality-of-Life Outcomes in Previously Untreated Patients With Nonsquamous Non–Small Cell Lung Cancer	8
Rectal Cancer—The Only Constant Is Change	8
DNA Damage Repair Inhibitors—Combination Therapies	8
Current State of Neoadjuvant Therapy for Locally Advanced Rectal Cancer	8
Overlooked and Damaging Impact of Structural Racism and Implicit Bias on US Health Care	8
Advances in Stereotactic Body Radiation Therapy for Lung Cancer	7
New Metabolomic Insights Into Cancer	7
Supportive Care for Patients With Myelodysplastic Syndromes	7
Overview of the Management of Higher-Risk Myelodysplastic Syndromes	7
Updates in the Management of Uveal Melanoma	7
Effective Personalization of Stereotactic Radiosurgery for Brain Metastases in the Modern Era	7
Menopausal Hormone Therapy and Breast Cancer	7
The Clinical Challenges, Trials, and Errors of Combatting Poly(ADP-Ribose) Polymerase Inhibitors Resistance	7
Telemedicine and cancer care: Barriers and strategies to optimize delivery: Erratum	6
Telehealth and Technology	6
Role of the Microbiome in Immunotherapy of Melanoma	6
Neurosurgical Advances for Malignant Gliomas	6
PI3K Inhibition for Squamous Cell Head and Neck Carcinoma	6
Introduction	6
Impact of Precision Medicine in Oncology	6
Discovery of Natural Products for Cancer Prevention	6
Evolution of Therapy for Older Patients With Acute Myeloid Leukemia	6
Hormone Replacement Therapy After Breast Cancer	6
The Current Role of Human Papillomavirus Circulating Tumor DNA in Oropharynx Cancer	6
A General Approach to Patients Presenting With Locally Advanced or Distant Metastatic Disease	6
Short- and Long-term Repercussions of Vancomycin on Immune Surveillance and the Efficacy of Antitumor Treatments	6
How Far We’ve Come	6
Evolving Landscape of Antibody Drug Conjugates in Lymphoma	6
Survival of the Fittest	5
The Challenges and Future of Immunotherapy for Gliomas	5
Individual Benefits and Risks of Intravaginal Estrogen and Systemic Testosterone in the Management of Women in the Menopause, With a Discussion of Any Associated Risks for Cancer Development	5
What Role Does Radiotherapy Play in the Molecular Era for Intrahepatic Cholangiocarcinoma?	5
Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms	5
Estrogen for the Treatment and Prevention of Breast Cancer	5
Telemedicine Across the Cancer Care Continuum	5
Current State of Cell Therapies for Genitourinary Malignancies	5
What to Eat for Cancer Prevention	4
STING Agonists in Head and Neck Squamous Cell Carcinoma	4
With Our Powers Combined	4
The Gut Microbiome and Pancreatic Cancer Development and Treatment	4
Antibody-Drug Conjugates in Myeloid Leukemias	4
Telemedicine and Cancer Care	4

Molecular Imaging of Steroid Receptors in Breast Cancer	4
The Lung Microbiome in Carcinogenesis and Immunotherapy Treatment	4
The Microbiome and Its Impact on Allogeneic Hematopoietic Cell Transplantation	4
Diagnostic and Therapeutic Application of Fibroblast Activation Protein Inhibitors in Oncologic and Nononcologic Diseases	4
Repurposing Drugs for Cancer Prevention	4
Gene Expression Profiles in Cancers and Their Therapeutic Implications	4
Impact of Precision Medicine in Oncology	4
Severe Lymphopenia Predicts Poorer Survival in Patients With Rectal Cancer Undergoing Neoadjuvant Chemoradiation	4
Recent Advances in Blood-Based Liquid Biopsy Approaches in Prostate Cancer	4
Epidemiology and Pathogenesis of Myelodysplastic Syndrome	3
Evolution of Response-Based Radiotherapy for Hepatocellular Cancer	3
Concerns About Compounded Bioidentical Menopausal Hormone Therapy	3
The Clinical Value of Plasma Epstein-Barr Virus DNA as a Tumor Marker in Nasopharyngeal Carcinoma: Prognostic? Yes, But How Can We Best Use It?	3
Circulating Biomarkers in Glioblastoma	3
PARP Inhibitors in Pancreatic Cancer	3
Stereotactic Body Radiotherapy in Oligomestatic/Oligoprogressive Sarcoma	3
Digital Health for Oncological Care	3
Chimeric Antigen Receptor T-Cell Therapy	3
Updates in Classification of Myelodysplastic Syndrome	3
Local Excision for Early-Stage Rectal Adenocarcinomas	3
Introduction	3
Advancements in Understanding and Preventing Obesity-Related Colon Cancer	3
Effective Image Communication of Hormone Replacement Therapy Risks and Benefits	3
Menin Inhibitors in Acute Myeloid Leukemia—What Does the Future Hold?	3
Checkpoint Inhibitors and Other Immune-Based Therapies in Acute Myeloid Leukemia	3
Adoptive Cell Therapy for Advanced Solid Tumors	3
Radiopharmaceuticals for Cancer Diagnosis and Therapy	3
Management of Low-Grade Gliomas	3
Beyond the COVID-19 Pandemic	3
Nuclear Medicine Cancer Care—Current Status and Future Directions for Radiopharmaceutical Diagnostics and Theranostics for Cancer	3
The Management of Low-Risk Myelodysplastic Syndromes—Current Standards and Recent Advances	3
Poly(ADP-Ribose) Polymerase Inhibition in Small Cell Lung Cancer	2
Menopausal Hormone Replacement Therapy and Reduction of All-Cause Mortality and Cardiovascular Disease	2
Molecular Testing for Diagnostics, Prognostication, and Treatment Stratification in Cancers	2
Diversity and Disparities in Lung Cancer Outcomes Among Minorities	2
Fecal Microbiota Transplantation as a Cancer Therapeutic	2
Treatment of Stage III Resectable Melanoma—Adjuvant and Neoadjuvant Approaches	2
The Utility of Interim Positron Emission Tomography Imaging to Inform Adaptive Radiotherapy for Head and Neck Squamous Cell Carcinoma	2
Targets for Cancer Prevention: Evolving Methodologies in Basic and Epidemiological Sciences Identify Interrelated Pathways and the Need for Holistic Approaches	2
Current State of Cell Therapies for Breast Cancer	2
Disparities in Gynecologic Cancers	2
New Roles of Poly(ADP-Ribose) Polymerase Inhibitors in the Treatment of Breast Cancer	2
PARP Inhibition in Advanced Prostate Cancer	2
A Review of Stereotactic Body Radiotherapy in the Management of Gastrointestinal Malignancies	2
Antibody-Drug Conjugates and Tissue-Agnostic Drug Development	2
The Promise of Cancer Health Justice	2
Neoantigen-Specific T Cells in Adoptive Cell Therapy	2
Telemedicine and Burnout—How Enhancing Operational Support Can Improve Digital Health Tools	2
DNA Damage Response in Glioblastoma	2
Shifting the Landscape of Spine and Non-Spine Bone Metastases	2
Combining Isocitrate Dehydrogenase Inhibitors With Existing Regimens in Acute Myeloid Leukemia	2
Hepatocellular Carcinoma—Southeast Asia Updates	2
Novel Approaches and Future Directions in Myelodysplastic Syndrome Treatment	2
Monoclonal Antibodies in Acute Myeloid Leukemia—Are We There Yet?	2
Theranostics in Neuroendocrine Tumors	2
Insights for Oncology Trials Garnered From the Rapid Development of an mRNA COVID-19 Vaccine	2
The Role of Circulating Tumor DNA for Management of Patients With Rectal Cancer	2
The Evolving Role of Allogeneic Stem Cell Transplant in the Era of Molecularly Targeted Agents	2
Precision Radiotherapy for Gliomas	2
Preclinical In Vitro and In Vivo Models for Adoptive Cell Therapy of Cancer	2
T3N0 Rectal Cancer	2
The Menopause Management Vacuum	2